-

Piper Sandler Expands Healthcare Investment Banking Team with the Addition of John Kerins

NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John Kerins as a managing director to the healthcare investment banking team. Kerins will continue to serve and support clients within the pharma services sector from the firm’s New York office.

“We are excited to welcome John to the team. His transaction experience combined with strong relationships across the pharma services landscape and with the leading healthcare private equity funds investing in the category are highly complementary to our healthcare investment banking practice. Pharma services is a rapidly growing segment of the market and a key focus for our healthcare investment banking platform. We are confident John’s skillset will enhance our ability to serve our clients and position Piper Sandler for long-term success in this market,” said J.P. Peltier, global group head of healthcare investment banking at Piper Sandler.

Prior to joining the firm, Kerins spent 10 years at Cain Brothers & Company, most recently as a managing director on their healthcare team advising clients on mergers and acquisitions. Before that, he was an investment banker at Deloitte for six years providing M&A advisory services. He received his bachelor’s degree from Kenyon College and his Master of Business Administration degree from Fordham University Gabelli School of Business.

“I am thrilled to be joining Piper Sandler. Their healthcare investment banking team has a trusted reputation of M&A leadership in addition to their deep healthcare services and biopharma research presence. I look forward to working with my new partners to further drive best-in-class client service,” said Kerins.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, a tied agent of AHP Capital Management GmbH, authorized and regulated by BaFin; and in Hong Kong through Piper Sandler Hong Kong Ltd., authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | X

©2025. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036

Contacts

Piper Sandler Companies
800 Nicollet Mall, Suite 900
Minneapolis, MN 55402

CONTACT
Nick Lawler
Tel: 212 891-8954
nick.lawler@psc.com

Piper Sandler Companies

NYSE:PIPR

Release Versions
$Cashtags

Contacts

Piper Sandler Companies
800 Nicollet Mall, Suite 900
Minneapolis, MN 55402

CONTACT
Nick Lawler
Tel: 212 891-8954
nick.lawler@psc.com

Social Media Profiles
More News From Piper Sandler Companies

Piper Sandler Appoints Aamer Naseer to Head of Life Sciences Outsourcing and B2B Med Tech

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the appointment of Aamer Naseer to global head of life sciences outsourcing and B2B med tech. “Aamer has built deep relationships across the life sciences ecosystem and has a strong track record of advising private equity firms, public companies and founders/entrepreneurs. His leadership, sector expertise and commitment to our clients position us exceptionally well to continue e...

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Jason Arnold

MINNEAPOLIS & LONDON--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Jason Arnold as a managing director in the healthcare investment banking group. Arnold will be initially based in London while serving clients globally. He will be advising life science tools and diagnostic companies on mergers and acquisitions, strategic partnerships and capital raising transactions. “We’re delighted to welcome Jason to the healthcare i...
Back to Newsroom